Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data setBlood, 2020-12, Vol.136 (26), p.3033-3040 [Peer Reviewed Journal]2020 American Society of Hematology ;2020 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2020008150 ;PMID: 33367546Full text available |
|
2 |
Material Type: Article
|
Unexpected parvovirus B19 infection in a patient with multiple myelomaBlood, 2023-09, Vol.142 (11), p.1026-1026 [Peer Reviewed Journal]2023 The American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023021561 ;PMID: 37707869Full text available |
|
3 |
Material Type: Article
|
Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working GroupThe lancet oncology, 2021-03, Vol.22 (3), p.e119-e130 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;info:eu-repo/semantics/openAccess ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30559-3 ;PMID: 33545067Full text available |
|
4 |
Material Type: Article
|
Myeloma bone disease: from biology findings to treatment approachesBlood, 2019-04, Vol.133 (14), p.1534-1539 [Peer Reviewed Journal]2019 American Society of Hematology ;2019 by The American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2018-11-852459 ;PMID: 30760454Full text available |
|
5 |
Material Type: Article
|
Multiple myeloma presenting with hepatic light chain depositionBlood, 2023-05, Vol.141 (19), p.2402-2402 [Peer Reviewed Journal]2023 The American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2023019997 ;PMID: 37166924Full text available |
|
6 |
Material Type: Article
|
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studiesBlood cancer journal (New York), 2022-02, Vol.12 (2), p.32-32, Article 32 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2044-5385 ;EISSN: 2044-5385 ;DOI: 10.1038/s41408-022-00629-1 ;PMID: 35210399Full text available |
|
7 |
Material Type: Article
|
An unusual case of a multiple myeloma with thyroid involvement at primary diagnosisBlood, 2023-03, Vol.141 (9), p.1092-1092 [Peer Reviewed Journal]2023 The American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2022018243 ;PMID: 36862432Full text available |
|
8 |
Material Type: Article
|
COVID-19 outcomes in patients with hematologic diseaseBone marrow transplantation (Basingstoke), 2020-11, Vol.55 (11), p.2180-2184 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 0268-3369 ;EISSN: 1476-5365 ;DOI: 10.1038/s41409-020-0931-4 ;PMID: 32376969Full text available |
|
9 |
Material Type: Article
|
Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple MyelomaCancer research (Chicago, Ill.), 2016-03, Vol.76 (5), p.1089-1100 [Peer Reviewed Journal]2016 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-15-1703 ;PMID: 26833121Full text available |
|
10 |
Material Type: Article
|
Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myelomaBlood, 2022-01, Vol.139 (1), p.137-142 [Peer Reviewed Journal]2022 American Society of Hematology ;Copyright © 2022 American Society of Hematology. All rights reserved. 2022 American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2021013429 ;PMID: 34657156Full text available |
|
11 |
Material Type: Article
|
European Myeloma Network guidelines for the management of multiple myeloma-related complicationsHaematologica (Roma), 2015-10, Vol.100 (10), p.1254-1266 [Peer Reviewed Journal]Copyright© Ferrata Storti Foundation. ;Copyright© Ferrata Storti Foundation 2015 ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2014.117176 ;PMID: 26432383Full text available |
|
12 |
Material Type: Article
|
Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myelomaBlood, 2017-06, Vol.129 (26), p.3452-3464 [Peer Reviewed Journal]2017 American Society of Hematology ;2017 by The American Society of Hematology. ;2017 by The American Society of Hematology 2017 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2017-03-773341 ;PMID: 28515094Full text available |
|
13 |
Material Type: Article
|
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patientsHaematologica (Roma), 2015-01, Vol.100 (1), p.107-113 [Peer Reviewed Journal]Copyright© Ferrata Storti Foundation. ;Copyright© Ferrata Storti Foundation 2015 ;ISSN: 0390-6078 ;ISSN: 1592-8721 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2014.107714 ;PMID: 25344526Full text available |
|
14 |
Material Type: Article
|
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple MyelomaJournal of clinical oncology, 2019-08, Vol.37 (22), p.1946-1955 [Peer Reviewed Journal]2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.00231 ;PMID: 31188726Full text available |
|
15 |
Material Type: Article
|
Response to mRNA vaccination for COVID-19 among patients with multiple myelomaLeukemia, 2021-12, Vol.35 (12), p.3534-3541 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature Limited 2021. ;The Author(s), under exclusive licence to Springer Nature Limited 2021 ;ISSN: 0887-6924 ;EISSN: 1476-5551 ;DOI: 10.1038/s41375-021-01354-7 ;PMID: 34326466Full text available |
|
16 |
Material Type: Article
|
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma NetworkLeukemia, 2021-01, Vol.35 (1), p.31-44 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0887-6924 ;ISSN: 1476-5551 ;EISSN: 1476-5551 ;DOI: 10.1038/s41375-020-01016-0 ;PMID: 32814840Full text available |
|
17 |
Material Type: Article
|
Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and ThrombusAdvanced materials (Weinheim), 2016-11, Vol.28 (43), p.9573-9580 [Peer Reviewed Journal]2016 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim ;2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. ;ISSN: 0935-9648 ;EISSN: 1521-4095 ;DOI: 10.1002/adma.201603463 ;PMID: 27626769Full text available |
|
18 |
Material Type: Article
|
VTE prophylaxis in multiple myelomaBlood, 2022-12, Vol.140 (23), p.2413-2414 [Peer Reviewed Journal]2022 The American Society of Hematology ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2022017517 ;PMID: 36480221Full text available |
|
19 |
Material Type: Article
|
Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in relapsed multiple myeloma patients with renal impairment: IKEMA subgroup analysisHaematologica (Roma), 2022-06, Vol.107 (6), p.1397-1409 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;Copyright© 2022 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2021.279229 ;PMID: 34647444Full text available |
|
20 |
Material Type: Article
|
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cellsHaematologica (Roma), 2024-02, Vol.109 (2), p.682-688 [Peer Reviewed Journal]Copyright© 2024 Ferrata Storti Foundation ;ISSN: 0390-6078 ;EISSN: 1592-8721 ;DOI: 10.3324/haematol.2023.283296 ;PMID: 37675514Full text available |